NCT01060475 - Safety and Tolerability of LIM-0705 in Healthy Male Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

May 31, 2010

Study Completion Date

June 30, 2010

Conditions

Healthy

Interventions

DRUG

LIM-0705 and tacrolimus

Oral solution, LIM-0705 500 mg BID for 14 days plus tacrolimus BID for first 8 days.

DRUG

LIM-0705 and tacrolimus

Oral solution, LIM-0705 750 mg BID for 14 days plus tacrolimus BID for the first 8 days.

DRUG

Placebo LIM-0705 and tacrolimus

Placebo oral solution BID for 14 days plus tacrolimus BID for the first 8 days.

DRUG

Drug LIM-0705 and placebo tacrolimus

Oral solution, LIM-0705 750 mg BID for 14 days plus placebo capsule BID for the first 8 days.

Trial Locations (2)

Nucleus Network CCS-Austin, Heidelberg

Nucleus Network CCS-AMREP, Prahran